PURPOSE: [(18)F]FDG has been used as an inflammation marker and shown to accumulate in inflammatory atherosclerotic plaques. The aim of this study was to investigate the uptake and location of [(18)F]FDG in atherosclerotic plaque compartments. METHODS: The biodistribution of intravenously administered [(18)F]FDG was analysed in atherosclerotic LDLR/ApoB48 mice (n=11) and control mice (n=9). Digital autoradiography was used to detect the ex vivo distribution in frozen aortic sections. In vitro binding of [(18)F]FDG in human atherosclerotic arteries was also examined. RESULTS: The uptake of [(18)F]FDG was significantly higher in the aorta of atherosclerotic mice as compared with the control mice. Autoradiography of excised arteries showed higher [(18)F]FDG uptake in the plaques than in the healthy vessel wall (mean ratio +/-SD 2.7+/-1.1). The uptake of [(18)F]FDG in the necrotic, calcified sites of the advanced atherosclerotic lesions was 6.2+/-3.2 times higher than that in the healthy vessel wall. The in vitro studies of human arterial sections showed marked binding of [(18)F]FDG to the calcifications but not to other structures of the artery wall. CONCLUSION: In agreement with previous studies, we observed [(18)F]FDG uptake in atherosclerotic plaques. However, prominent non-specific binding to calcified structures was found. This finding warrants further studies to clarify the significance of this non-specific binding in human plaques in vivo.
PURPOSE: [(18)F]FDG has been used as an inflammation marker and shown to accumulate in inflammatory atherosclerotic plaques. The aim of this study was to investigate the uptake and location of [(18)F]FDG in atherosclerotic plaque compartments. METHODS: The biodistribution of intravenously administered [(18)F]FDG was analysed in atheroscleroticLDLR/ApoB48mice (n=11) and control mice (n=9). Digital autoradiography was used to detect the ex vivo distribution in frozen aortic sections. In vitro binding of [(18)F]FDG in humanatherosclerotic arteries was also examined. RESULTS: The uptake of [(18)F]FDG was significantly higher in the aorta of atheroscleroticmice as compared with the control mice. Autoradiography of excised arteries showed higher [(18)F]FDG uptake in the plaques than in the healthy vessel wall (mean ratio +/-SD 2.7+/-1.1). The uptake of [(18)F]FDG in the necrotic, calcified sites of the advanced atherosclerotic lesions was 6.2+/-3.2 times higher than that in the healthy vessel wall. The in vitro studies of human arterial sections showed marked binding of [(18)F]FDG to the calcifications but not to other structures of the artery wall. CONCLUSION: In agreement with previous studies, we observed [(18)F]FDG uptake in atherosclerotic plaques. However, prominent non-specific binding to calcified structures was found. This finding warrants further studies to clarify the significance of this non-specific binding in human plaques in vivo.
Authors: Terence M Doherty; Hiroyasu Uzui; Lorraine A Fitzpatrick; Pinky V Tripathi; Colin R Dunstan; Kamlesh Asotra; Tripathi B Rajavashisth Journal: FASEB J Date: 2002-04 Impact factor: 5.191
Authors: Pia Leppänen; Suvi Koota; Ivana Kholová; Jonna Koponen; Christina Fieber; Ulf Eriksson; Kari Alitalo; Seppo Ylä-Herttuala Journal: Circulation Date: 2005-08-30 Impact factor: 29.690
Authors: L Powell-Braxton; M Véniant; R D Latvala; K I Hirano; W B Won; J Ross; N Dybdal; C H Zlot; S G Young; N O Davidson Journal: Nat Med Date: 1998-08 Impact factor: 53.440
Authors: M M Véniant; C H Zlot; R L Walzem; V Pierotti; R Driscoll; D Dichek; J Herz; S G Young Journal: J Clin Invest Date: 1998-10-15 Impact factor: 14.808
Authors: Terence M Doherty; Lorraine A Fitzpatrick; Daisuke Inoue; Jian-Hua Qiao; Michael C Fishbein; Robert C Detrano; Prediman K Shah; Tripathi B Rajavashisth Journal: Endocr Rev Date: 2004-08 Impact factor: 19.871
Authors: J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg Journal: Circulation Date: 2002-06-11 Impact factor: 29.690
Authors: Yan Zhao; Songji Zhao; Yuji Kuge; William H Strauss; Francis G Blankenberg; Nagara Tamaki Journal: Mol Imaging Biol Date: 2011-08 Impact factor: 3.488
Authors: Jin Liu; William S Kerwin; James H Caldwell; Marina S Ferguson; Daniel S Hippe; Adam M Alessio; Vanesa Martinez-Malo; Kristi Pimentel; Robert S Miyaoka; Ted R Kohler; Thomas S Hatsukami; Chun Yuan Journal: Int J Cardiovasc Imaging Date: 2015-08-18 Impact factor: 2.357
Authors: Iina Laitinen; Päivi Marjamäki; Kjell Någren; V Jukka O Laine; Ian Wilson; Pia Leppänen; Seppo Ylä-Herttuala; Anne Roivainen; Juhani Knuuti Journal: Eur J Nucl Med Mol Imaging Date: 2008-08-19 Impact factor: 9.236